MENU
+Compare
XGN
Stock ticker: NASDAQ
AS OF
Dec 23, 04:47 PM (EDT)
Price
$4.84
Change
-$0.31 (-6.02%)
Capitalization
27.06M

XGN Exagen Forecast, Technical & Fundamental Analysis

a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases

XGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for XGN with price predictions
Dec 20, 2024

XGN's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Oscillator for XGN moved out of overbought territory on December 18, 2024. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 instances where the indicator moved out of the overbought zone. In of the 24 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 41 cases where XGN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for XGN turned negative on December 20, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XGN broke above its upper Bollinger Band on December 11, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

XGN moved above its 50-day moving average on November 14, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for XGN crossed bullishly above the 50-day moving average on November 19, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XGN advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 119 cases where XGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.192) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.528) is also within normal values, averaging (43.338).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
XGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

XGN is expected to report earnings to rise 12.61% to -31 cents per share on March 24

Exagen XGN Stock Earnings Reports
Q4'24
Est.
$-0.32
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.18
Q1'24
Beat
by $0.17
Q4'23
Beat
by $0.12
The last earnings report on November 12 showed earnings per share of -28 cents, beating the estimate of -28 cents. With 65.80K shares outstanding, the current market capitalization sits at 27.06M.
A.I. Advisor
published General Information

General Information

a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
1261 Liberty Way
Phone
+1 760 560-1501
Employees
179
Web
https://www.exagen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AFCG8.970.25
+2.87%
Advanced Flower Capital Inc
MTD1230.7424.72
+2.05%
Mettler-Toledo International
AEON0.65N/A
+0.08%
AEON Biopharma
ADMA17.40-0.50
-2.79%
ADMA Biologics
SCHL19.81-5.03
-20.25%
Scholastic Corp

XGN and Stocks

Correlation & Price change

A.I.dvisor tells us that XGN and DRIO have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XGN and DRIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XGN
1D Price
Change %
XGN100%
+9.34%
DRIO - XGN
24%
Poorly correlated
+8.09%
ESTA - XGN
24%
Poorly correlated
+2.75%
NTRA - XGN
24%
Poorly correlated
+2.40%
INGN - XGN
23%
Poorly correlated
+2.05%
BIOQ - XGN
23%
Poorly correlated
N/A
More